Two New Liver Fibrosis Rodent Models Launched by Crown Bioscience

SAN DIEGO, March 10 (Korea Bizwire) — Crown Bioscience today announced the launch of two new liver fibrosis rodent models, allowing more rapid and cost-effective evaluation of the preclinical effects of NASH and anti-fibrotic treatments on acute liver injury, advanced fibrosis, and/or fibrosis reversal. The two models encompass fibrosis induced by carbon tetrachloride and a [...]